DOMS EARLY REINTERVENTION (ERI) EXPERIMENT
DOMS 早期再干预 (ERI) 实验
基本信息
- 批准号:6378714
- 负责人:
- 金额:$ 54.07万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1999
- 资助国家:美国
- 起止时间:1999-08-01 至 2003-07-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
While most clinicians view substance use as a chronic relapsing condition that may require multiple episodes of care, most research to date has focused on single episodes of care. Recent emphasis on outcome based contracts and/or capitated cost contracts has stimulated interest in better managing clients "across" multiple admissions and/or in a continuum of care model. In the treatment of other chronic illnesses quarterly, semi-annual or annual check-ups are often integral parts of aftercare which check for early indications of relapse and attempt early re-intervention before the condition and consequences worsen. The specific aims of this study are to determine the relative effectiveness of an Early Re-Intervention (ERI) protocol in terms of its ability to: 1) reduce the time to treatment re-entry and increase the rates of early treatment re-entry, and, 2) improve long-term outcomes related to a) substance use, HIV risk behaviors, illegal activity, b) training- and employment-related behaviors, and c) utilization of expensive services (e.g., inpatient substance abuse treatment, inpatient mental health treatment, emergency room admissions, hospital nights, days in jail, days of their children being in foster care or institutions). To evaluate ERI, 800 new clients with substance use disorders will be recruited from two central intake units, one located in Chicago and another in Central Illinois. Clients will be blocked into one of five severity groups (based on drug dependence, alcohol dependence, and frequency of use) then randomly assigned to either quarterly outcome monitoring (OM) with 20-30 minute assessments for 18 months or quarterly OM plus ERI. Response of participants in the ERI condition will be used to determine the participants linkage assistance needs every quarter. ERI Linkage Managers will provide the qualified participants with linkage assistance including feedback on their current substance use and need for treatment, motivational discussions to convince them to consider returning to treatment, and then direct assistance in helping them make and keep a readmission appointment. Through feedback, social reinforcement, and assistance to access care, ERI is expected to reduce the time to readmission, increase the rate of early treatment re-admissions, and consequently, improve long-term outcomes. Significant findings in favor of the ERI protocol would provide a better understanding of the clinical value of outcome monitoring and a straightforward, replicable protocol for improving the long-term effectiveness of drug treatment.
尽管大多数临床医生将使用物质使用视为可能需要多个护理的慢性复发状况,但迄今为止,大多数研究都集中在单个护理上。 最近强调基于结果的合同和/或承受的成本合同,激发了人们对更好地管理客户的兴趣”,“在“多次入学”和/或连续的护理模型中。在季度治疗其他慢性疾病的过程中,半年度或年度检查通常是护理的组成部分,该部分检查是否会在病情和后果恶化之前早期复发并尝试早期重新干预。 The specific aims of this study are to determine the relative effectiveness of an Early Re-Intervention (ERI) protocol in terms of its ability to: 1) reduce the time to treatment re-entry and increase the rates of early treatment re-entry, and, 2) improve long-term outcomes related to a) substance use, HIV risk behaviors, illegal activity, b) training- and employment-related behaviors, and c) utilization of expensive services (e.g.,住院药物滥用治疗,住院心理健康治疗,急诊室入院,住院之夜,入狱日期,孩子在寄养或机构中的日子)。为了评估ERI,将从两个中央进气单元,一个位于芝加哥,另一个位于伊利诺伊州中部,将招募800名具有药物使用障碍的新客户。 然后将客户封锁为五个严重性组之一(基于药物依赖,酒精依赖和使用频率),然后随机分配给季度结果监测(OM),并在18个月内进行20-30分钟的评估或季度OM加ERI。 在ERI条件下的参与者的响应将用于确定每个季度的参与者链接援助需求。 ERI Linkage经理将为合格的参与者提供连锁协助,包括有关他们当前的物质使用和治疗需求的反馈,激励性讨论说服他们考虑重返治疗,然后直接帮助他们进行和保持再入院任命。 通过反馈,社会加强和辅助访问护理,ERI有望减少再入院的时间,提高早期治疗率的速度,从而改善长期结局。有利于ERI方案的重大发现将更好地理解结果监测的临床价值以及一种直接,可复制的方案,以提高药物治疗的长期有效性。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MICHAEL L DENNIS其他文献
MICHAEL L DENNIS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MICHAEL L DENNIS', 18)}}的其他基金
Improving Retention across the OUD Service Cascade upon Re-entry from Jail using Recovery Management Checkups
使用恢复管理检查提高从监狱重新进入时整个 OUD 服务级联的保留
- 批准号:
10401769 - 财政年份:2019
- 资助金额:
$ 54.07万 - 项目类别:
Improving Retention across the OUD Service Cascade upon Re-entry from Jail using Recovery Management Checkups
使用恢复管理检查提高从监狱重新进入时整个 OUD 服务级联的保留
- 批准号:
10615752 - 财政年份:2019
- 资助金额:
$ 54.07万 - 项目类别:
TRIALS Coordinating Center to Reduce Substance Use, HIV Risk Behaviors, & Crime
减少药物使用、艾滋病毒危险行为试验协调中心,
- 批准号:
8587391 - 财政年份:2013
- 资助金额:
$ 54.07万 - 项目类别:
TRIALS Coordinating Center to Reduce Substance Use, HIV Risk Behaviors, & Crime
减少药物使用、艾滋病毒危险行为试验协调中心,
- 批准号:
8688979 - 财政年份:2013
- 资助金额:
$ 54.07万 - 项目类别:
TRIALS Coordinating Center to Reduce Substance Use, HIV Risk Behaviors, & Crime
减少药物使用、艾滋病毒危险行为试验协调中心,
- 批准号:
9923816 - 财政年份:2013
- 资助金额:
$ 54.07万 - 项目类别:
TRIALS Coordinating Center to Reduce Substance Use, HIV Risk Behaviors, & Crime
减少药物使用、艾滋病毒危险行为试验协调中心,
- 批准号:
9308904 - 财政年份:2013
- 资助金额:
$ 54.07万 - 项目类别:
Smartphone Addiction Recovery Coach for Young Adults (SARC-YA) Experiment
年轻人智能手机成瘾康复教练 (SARC-YA) 实验
- 批准号:
10405415 - 财政年份:1999
- 资助金额:
$ 54.07万 - 项目类别:
相似国自然基金
面向临床实施的早期胃癌智能诊断方法研究
- 批准号:62306136
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于影像-基因-临床多尺度弥漫性大B细胞淋巴瘤复发及预后风险精准量化评估研究
- 批准号:82372025
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
面向肝癌射频消融的智能建模与快速动力学分析方法研究及其临床验证
- 批准号:62372469
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
cNEIL3-130aa调控肾细胞癌糖代谢重编程的作用机制及其临床价值研究
- 批准号:82302613
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
MUC5B/Siglec途径对RA-ILD巨噬细胞胞葬的作用机制及临床价值研究
- 批准号:82302605
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
NIDA Clinical Trials Network: New York Node
NIDA 临床试验网络:纽约节点
- 批准号:
10855627 - 财政年份:2023
- 资助金额:
$ 54.07万 - 项目类别:
Adapting and Piloting Behavioral Activation for Veterans with Co-Occurring AUD and Posttraumatic Stress Disorder
为同时患有 AUD 和创伤后应激障碍的退伍军人调整和试点行为激活
- 批准号:
10886182 - 财政年份:2023
- 资助金额:
$ 54.07万 - 项目类别:
Yuva Sath: A peer-led intervention to support substance use treatment and HIV prevention among young people who inject drugs in India
Yuva Sath:一项由同伴主导的干预措施,旨在支持印度注射吸毒年轻人的药物滥用治疗和艾滋病毒预防
- 批准号:
10698376 - 财政年份:2023
- 资助金额:
$ 54.07万 - 项目类别:
Improving cross ancestry polygenic prediction of tobacco and alcohol use
改进烟草和酒精使用的跨血统多基因预测
- 批准号:
10739557 - 财政年份:2023
- 资助金额:
$ 54.07万 - 项目类别: